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012.08.0Abstract Background: Slow coronary ﬂow (SCF) is deﬁned as late opaciﬁcation at the epicardial
coronary arteries without stenosis, in this study we search the effect of isolated CSF on P-wave and
QT-interval dispersion.
Patients and methods: Thirty ﬁve patients with CSF (group 1), and 30 control subjects (group II)
matched in sex and age. Both groups underwent a standard 12-lead surface electrocardiogram.
Maximal (P max), minimal P-wave durations (P min), P dispersion (PD), and QT dispersion were
measured. All patients underwent selective coronary angiography. Coronary ﬂow rates were docu-
mented by Thrombolysis in Myocardial Infarction (TIMI) frame count.
Results: CSF patients had more P maximum, P dispersion, C QT duration, QT dispersion, and C
QT dispersion. TIMl frame counts of CSF patients were signiﬁcantly higher than those of the con-
trol group for all three coronary vessels (P 0.0001). PD was positively correlated with LAD TIMI
frame count (r= 0.42; P: 0.01); LCx TIMI frame count (r= 0.40; P: 0.01); and mean TIMI frame
count (r= 0.44; P: 0.007), while weak correlated with RCA TIMI frame count (r= 0.22; and not
statistically signiﬁcant P: 0.18), C QT dispersion was positively correlated with LAD TIMI frame
count (r= 0.54; P: 0.001); LCx TIMI frame count (r= 0.70; P: 0.001); and mean TIMI frame
count (r= 0.50; P: 0.002), while weak correlated with RCA TIMI frame count (r= 0.24; and
not statistically signiﬁcant P: 0.15).
Conclusion: CSF was found to be associated with prolonged dispersion of P-wave and QT-interval.
ª 2012 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.102554137.
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021. Introduction
The coronary slow ﬂow phenomenon (CSFP) is an angio-
graphic ﬁnding characterized by delayed opaciﬁcation of the
distal vasculature in the absence of obstructive epicardial cor-
onary artery disease (CAD).1 CSFP is a coronary microvascu-
lar disorder.2 It is clinically distinct from other coronary
microvascular disorders3 and is important to diagnose as effec-
tive therapies have been described.4 A distinguishing clinicalg by Elsevier B.V. All rights reserved.
176 K. Mahmoudfeature of this disorder is its associated acute coronary syn-
drome (ACS) presentation typically observed as the index
manifestation.5 Tambe et al.6 ﬁrst described cases of angina
pectoris in patients with decreased coronary blood ﬂow rates
though no atherosclerotic lesion was present. The clinical sig-
niﬁcance, etiology, and pathophysiologic mechanisms of this
angiographic phenomenon have not been well deﬁned. Micro-
vascular dysfunction, endothelial and vasomotor dysfunction,
occlusive disease of small coronary arteries, and myocardial
ischemia are all associated with impaired coronary blood
ﬂow.7–10 P-wave abnormalities, detected in the electrocardio-
gram (ECG), have been thought to reﬂect left atrial enlarge-
ment,11 left atrial hypertension12 and altered conduction.13 A
simple ECG marker, P-wave dispersion (PD), has been used
to evaluate the intra atrial and inter atrial conduction times
and the inhomogeneous propagation of sinus impulses which
are well known electrophysiologic characteristics of the atrium
prone to ﬁbrillation.14,15 Prolonged P-wave duration and PD
have been reported to represent an increased risk for atrial
ﬁbrillation (AF) in patients with no underlying heart dis-
ease.14,15 Increased P max and PD are also related to stable an-
gina pectoris,16 acute coronary syndromes,17 coronary slow
ﬂow phenomenon18 and those undergoing coronary artery by-
pass surgery.19 Atrial ﬁbrillation (AF) is a rhythm disorder
commonly encountered in clinical practice.20 Ischemia, sys-
temic inﬂammation, increased oxidative stress, and increased
sympathetic activity play a signiﬁcant role in AF pathogene-
sis.21–23 It has been shown that SCF phenomenon is associated
with increased plasma levels of inﬂammatory markers, oxida-
tive stress parameters, increased sympathetic activity, and
myocardial ischemia.24–26 Hence, the risk of new development
and/or recurrence of AF may be increased in these patients.
QT dispersion (maximum QT interval minus minimum QT
interval) was originally proposed as an index of the spatial dis-
persion of ventricular recovery times in an attempt to distin-
guish myocardium that is homogeneous from myocardium
that displays inhomogeneity. However, QT dispersion does
not directly reﬂect the dispersion of recovery times, but results
mainly from variations in T wave morphology and the error in
QT interval measurement.27,28
2. The aim of the study
The aim of the study was to evaluate P-duration, PD and QT
dispersion in patients with CSF and its relationship with
Thrombolysis in Myocardial Infarction frame count in com-
parison to normal subjects.
3. Methods
The study consisted of 35 patients with CSF and otherwise
normal epicardial coronary arteries (group I) and 30 sex-
and age-matched subjects with atypical chest pain but normalExclu
Left ventricular dysfunction Atria
Evidence of any other intraventricular conduction defect Electr
Left ventricular hypertrophy Hype
Ventricular preexcitation Renacoronary arteries (group II) at the time from March 2008 and
November 2011.
3.1. Laboratory investigations
Blood samples were drawn from an antecubital vein after a 14-
h overnight fast. Blood urea, creatinine, fasting blood sugar,
lipid proﬁle and other biochemical parameters were deter-
mined by standard methods.
3.2. Echocardiology
All patients underwent transthoracic echocardiographic exam-
ination to asses left ventricular dimensions and function and
exclude valvular disorders.
3.3. Coronary angiography
All study participants had been referred to coronary angiogra-
phy because of exertional chest pain suggestive of stable angi-
na pectoris and/or positive responses to exercise stress
electrocardiography testing and abnormal myocardial perfu-
sion scintigraphy. All patients underwent selective coronary
angiography. Coronary ﬂow rates of all subjects were docu-
mented by Thrombolysis in Myocardial Infarction (TIMI)
frame count. Thrombolysis in Myocardial Infarction frame
count method is a simple, reproducible, objective, and quanti-
tative index of coronary ﬂow velocity.29 It has been suggested
that a higher TIMI frame count may reﬂect disordered resis-
tance vessel function.29 Thrombolysis in Myocardial Infarction
frame count was determined for each major coronary artery in
each patient and control subject according to the method ﬁrst
described by Gibson et al.29 Brieﬂy, the number of cineangio-
graphic frames, recorded at 30 frames per second, required for
the leading edge of the column of radiographic contrast to
reach a predetermined landmark is determined. The ﬁrst frame
is deﬁned as the frame in which concentrated dye occupies the
full width of the proximal coronary artery lumen, touching
both borders of the lumen and forward motion down the ar-
tery. The ﬁnal frame is designated when the leading edge of
the contrast column initially arrives at the distal landmark.
In the left anterior descending (LAD) coronary artery, the
landmark used is the most distal branch nearest the apex of
the left ventricle, commonly referred as the whale’s tail. Left
anterior descending coronary artery is usually longer than
the other major coronary arteries30; the TIMI frame count
for this vessel is often higher. To obtain corrected TIMI frame
count for LAD coronary artery, TIMI frame count was di-
vided by 1.7.29 The right coronary artery (RCA) distal land-
mark is the ﬁrst branch of the posterolateral RCA after the
origin of the posterior descending artery, regardless of the size
of this branch. The branch of the left circumﬂex (LCx) artery
that encompassed the greatest total distance traveled bysion criteria
l ﬁbrillation Bundle-branch block
olyte abnormalities
rthyroidism Chronic obstructive pulmonary disease
l, hepatic dysfunction Any history of systemic disease
Table 1 Clinical data of patients with CSF and control group.
Variable Group I n:35 Group II n:30 P
Age (y) 58.4 ± 6.7 60.5 ± 5.5 0.19
Sex (female/male) 22/13 18/12 NS
Body mass index (kg/m) 26 ± 0.02 25 ± 0.9 0.77
SBP (mmHg) 132 ± 9.7 128 ± 6 0.06
DBP (mmHg) 80.4 ± 2.8 79.9 ± 1.5 0.39
FH (%) 16 (45.7) 15 (50) NS
Smokers (%) 10 (50) 9 (50) NS
Aspirin (%) 30 (85.7) 25 (83.3) NS
ACEI/ARB (%) 16 (45.7) 15 (50) NS
Beta blockers (%) 21 (60) 19 (63.3) NS
Calcium channel (%)
blockers
6 (17) 5 (16) NS
Nitrates (%) 12 (34) 11 (36.6) NS
Statin (%) 13 (37) 11 (36) NS
SBP: systolic blood pressure; DBP: diastolic blood pressure; FH:
family history; DM: diabetes mellitus; ACEI/ARB: angiotensin
converting enzyme inhibitor; ARB: angiotensin II receptor blocker.
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artery. Thrombolysis in Myocardial Infarction frame count
in the LAD and LCx arteries was assessed in a right anterior
oblique projection with caudal angulation and RCA in left
anterior oblique projection with cranial angulation. The mean
TIMI frame count for each patient and control subject was
calculated by adding the TIMI frame counts for LAD, LCx,
and RCA and then dividing the obtained value by 3.
ECG parameters: P-wave dispersion measurements on 12-
lead ECGs All standard 12-lead ECGs were obtained using a
recorder (Fukuda Denshi Cardiomax Fx- 211) set at a
50 mm/s paper speed and 2 mV/cmV standardization. All mea-
surements of P-wave duration were calculated blindly by 2
observers. The onset of the P wave was deﬁned as the point
of ﬁrst visible upward slope from baseline for positive wave-
forms and as the point of ﬁrst downward slope from baseline
for negative waveforms. The return to the baseline was consid-
ered as the end of the P wave. The P max measured in any of
the 12 leads of the surface ECG was used as the longest atrial
conduction time. The difference between the P max and the P
min was calculated and deﬁned as PD. QT interval was mea-
sured from the onset of the QRS complex to the end of the
T wave, deﬁned as the return to the T-P is to electric line. If
the T wave could not be clearly determined, that lead was ex-
cluded. The mean of 3 consecutive intervals in each analyzable
lead was taken for analysis. QT dispersion was deﬁned as the
difference between the longest and shortest QT intervals and
the rate corrected with Bazett’s formula.31
4. Statistical analyses
All analyses were conducted using SPSS. Version 11. All group
data are expressed as mean ± standard deviation. The two
groups were compared for unpaired data, using the Student
t-test to evaluate the difference between the patients with
CSF and the controls. Pearson correlation analysis was per-
formed for reproducibility of PD and C QT dispersion. A P
value of <0.05 was considered signiﬁcant.
5. Results
The study population included 35 patients with CSF group I
(22 male, 13 female, mean age 58.4 ± 6.7) and 30 sex- and
age-matched subjects with typical ischemic chest pain but with
normal coronary arteries group II (18 male, 12 female, mean
age 60.5 ± 5.5).
As regards clinical data of both groups there was no statis-
tically signiﬁcant difference between patients with CSF (group
I) and the control group as regards, age, sex, body mass index,
SBP, DBP, percent of (FH of premature CAD, smokers), and
drug intake Table 1.
As regards laboratory data of both groups patients with
CSF had more urea and creatinine levels than the control while
there was no signiﬁcant difference as regards fasting blood su-
gar and lipid proﬁle Table 2. There was no statistically signif-
icant difference between CSF patients and the control group as
regards all the echo data, while CSF patients had more P
maximum (121.8 ± 7.5), P dispersion (38.1 ± 7.4), C QT
duration(405.3 ± 5.9), QT dispersion(32.2 ± 2.3), and C QT
dispersion(33.5 ± 2.5), than the control P maximum
(101.2 ± 5), P dispersion (20.7 ± 5), C QT duration(388.6 ±0.9), QT dispersion(27.4 ± 0.5), and C QT dispersion(28.5 ±
0.5). Table 3, and Figs. 1 and 2.
Thrombolysis in Myocardial Infarction frame counts of
CSF patients was signiﬁcantly higher than those of the control
group for all 3 coronary vessels (P 0.0001) Table 4.
In correlation analysis, Pd was positively correlated with
LAD TIMI frame count (r= 0.42; P: 0.01); LCx TIMI frame
count (r= 0.40; P: 0.01); and mean TIMI frame count
(r= 0.44; P: 0.007), while weak correlated with RCA TIMI
frame count (r= 0.22; and not statistically signiﬁcant P:
0.18) Table 5.
In another correlation analysis, C QT dispersion was posi-
tively correlated with LAD TIMI frame count (r= 0.54; P:
0.001; LCx TIMI frame count (r= 0.70; P: 0.001); and mean
TIMI frame count (r= 0.50; P: 0.002), while weak correlated
with RCA TIMI frame count (r= 0.24; and not statistically
signiﬁcant P: 0.15) Table 6.
6. Discussion
CSF cases account for 1–4% of angiographic studies in pa-
tients with ACS.32 Several mechanisms have been proposed
for the etiology of SCF, including occlusion of small vessels,
increased microvascular resistance, and diffuse atherosclero-
sis.33,34 However, the exact underlying pathophysiological
mechanisms as well as the clinical importance of this unique
angiographic phenomenon are not fully understood at present.
Recent data indicated that, besides other mechanisms, endo-
thelial activation and inﬂammation may play a pivotal role
in the pathogenesis of SCF.35 In this study patients with
SCF had more increase in urea and creatinine than the control
and this in agreement with KOC et al.36 In the present study in
patients SCF was associated with prolonged P-wave duration
and increased PD than the control. This is in agreement with
DOGAN et al.37 PD is a new electrocardiographic marker that
has been associated with the inhomogeneous and discontinu-
ous propagation of sinus impulses, and the correlation between
the presence of intraatrial conduction abnormalities and the
induction of paroxysmal AF has been well documented.38,39
PD is described as a noninvasive indicator of AF risk, which
Table 2 Laboratory data of patients with CSF and control group.
Variable Group I n:35 Group II n:30 P
Fasting blood glucose (mg/dl) 77.5 ± 4.5 78.1 ± 4.4 0.28
Urea (mg/dl) 32.1 ± 4.1 29.3 ± 4.8 0.01
Creatinine (mg/dl) 0.99 ± 0.07 0.91 ± 0.11 0.001
LDL-C (mg/dl) 118.6 ± 14.2 113.2 ± 9.3 0.08
HDL-C (mg/dl) 33.3 ± 2.7 33.5 ± 2.9 0.72
Triglycerides (mg/dl) 160.6 ± 33.9 162.8 ± 23.9 0.76
LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol.
Table 3 Echo & ECG data in CSF patients and control
group.
Variable Group I n: 35 Group II n:30 P
EDD (mm) 45.2 ± 2.7 43.9 ± 3.2 0.09
ESD (mm) 33 ± 1.4 32.6 ± 1.7 0.22
IVS (mm) 10.6 ± 1.7 9.5 ± 3.4 0.09
PW (mm) 9.6 ± 0.9 9.3 ± 0.7 0.13
EF% 58.3 ± 3.7 59.7 ± 2.4 0.07
LA (mm) 38 ± 9 43 ± 7 0.39
P max (ms) 121.8 ± 7.5 101.2 ± 5 0.001
P min (ms) 81.4 ± 5.5 82.1 ± 5.5 0.64
PD (ms) 38.1 ± 7.4 20.7 ± 5 0.001
C QT duration (ms) 405.3 ± 5.9 388.6 ± 0.9 0.001
QT dispersion (ms) 32.2 ± 2. 3 27.4 ± 0.5 0.001
C QT dispersion (ms) 33.5 ± 2.5 28.5 ± 0.5 0.001
EDD: end diastolic diameter; ESD: end systolic diameter; IVS:
interventricular septum; PW: posterior wall; EF: ejection fraction;
LA: left atrium; PD: P dispersion; C QT: corrected QT interval; C
QT dispersion: corrected QT dispersion.
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Figure 1 Comparison between P dispersion in patients with CSF
& the control group.
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Figure 2 Comparison between C QTD and QTD in patients
with CSF & the control group.
Table 4 TIMI frame count angiographic data of patients with
CSF and control group.
Variable Group I n:35 Group II n:30 P
LAD 42.4 ± 2.4 16.6 ± 1.2 0.0001
LCX 32.9 ± 1.8 15.6 ± 1.2 0.0001
RCA 29.4 ± 5.4 14 ± 1.2 0.0001
Mean 34.6 ± 2.4 15.5 ± 0.9 0.0001
LAD: left anterior descending coronary artery; LCX: left circum-
ﬂex coronary artery; RCA: right coronary artery.
Table 5 Correlation between PD and TIMI frame count
angiographic data of CSF patients.
Variable Pearson correlation P
LAD 0.42 0.01
LCX 0.40 0.01
RCA 0.22 0.18
Mean 0.44 0.007
LAD: left anterior descending coronary artery; LCX: left circum-
ﬂex coronary artery; RCA: right coronary artery.
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physiological properties of atrial myocardium prone to ﬁbril-
late due to atrial conduction abnormalities could possibly
result in prolonged and highly variable P waves that can be re-
ﬂected in differently oriented ECG leads. P-wave dispersion is
derived from a standard, simultaneously recorded 12-lead
ECG and is used as a marker of the interlead variation in
P-wave duration.40,41 P max and PD are widely used for pre-
diction of AF in various heart diseases.42,43 There are several
potential mediators between CAD and AF. Atrial ischemia isone of them. Increased heterogeneity of refractoriness, which
is present in ischemic conditions, is a known substrate for
AF.44 Moreover, impairment in autonomic cardiac function
Table 6 Correlation between C QT dispersion and TIMI
frame count of CSF patients.
Variable Pearson correlation P
LAD 0.54 0.001
LCX 0.70 0.001
RCA 0.24 0.15
Mean 0.50 0.002
LAD: left anterior descending coronary artery; LCX: left circum-
ﬂex coronary artery; RCA: right coronary artery.
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CAD. P-wave durations have been reported to be inﬂuenced
by the autonomic tone.45 It is well known that autonomic car-
diac function is impaired, and sympathetic activity is elevated
in patients with CAD.46 Impaired autonomic cardiac function
that correlated with the severity of CAD45 and increased sym-
pathetic activity may affect intra-atrial and interatrial conduc-
tion times and may increase PD in these patients. It has also
been reported that increased sympathetic activity causes a sig-
niﬁcant increase in PD. Thus, if SCF phenomenon is assumed
as a subgroup of syndrome X, the observed increase in PD
might have resulted from altered cardiac autonomic modula-
tion.47 Celik et al.48 implied that poor TIMI myocardial perfu-
sion grade immediately after primary percutaneous coronary
intervention can cause Pd and Pmax prolongation and sug-
gested that the increased Pd and Pmax in patients with poor
TIMI myocardial perfusion after primary percutaneous coro-
nary intervention is a result of the ongoing tissue ischemia
inducing inhomogeneous and discontinuous atrial conduction.
Recently, it has been shown that Pmax and Pd that are predic-
tors of AF are higher in CSF patients than controls.49 The
presence of ischemia and prolonged TIMI frame count in
SCF patients might be because of Pd and Pmax prolongation
and risk of development of AF.50 This was in agreement with
this study that found positive correlation between PD and
mean TIMI frame count in patients with CSF. A single global
QT interval measurement from the 12 lead ECG has been the
standard measure, but recently there has been a great interest
in the distribution of the QT intervals, at a given instant of
time, across the 12 lead Electrocardiogram (ECG) leads. This
parameter is called as QT dispersion (QTd). The QTd is emerg-
ing as an important new clinic tool as it has proposed as a mar-
ker of the risk of sudden cardiac death after Myocardial
Infarction.51 Increased QTd has important clinical implication
in patients with a wide range of heart disorders.52 we found in
this study that patients with CSF was associated with pro-
longed QT-interval duration and increased QTd. Increased dis-
persion of repolarization is known to be an important factor in
the development of ventricular arrhythmias.53
7. Conclusion
CSF was found to be associated with prolonged dispersion of
P-wave and QT-interval. We found that ischemia caused by
CSF may increase PD & P max, and C QT dispersion based
on a signiﬁcant positive correlation between PD and C QT dis-
persion with mean TIMI frame count. The possible mecha-
nisms may be microvascular ischemia and/or altered
autonomic control of the cardiovascular system observed inthis group of patients underlying mechanisms and prognostic
implications should be assessed in the future.
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